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The ability to probe defined neural circuits with both the spatial and temporal resolution
imparted by optogenetics has transformed the field of neuroscience. Although much
attention has been paid to the advantages of manipulating neural activity at millisecond
timescales in order to elicit time-locked neural responses, little consideration has been
given to the manipulation of circuit activity at physiologically relevant times of day, across
multiple days. Nearly all biological events are governed by the circadian clock and exhibit
24 h rhythms in activity. Indeed, neural circuit activity itself exhibits a daily rhythm with
distinct temporal peaks in activity occurring at specific times of the day. Therefore,
experimentally probing circuit function within and across physiologically relevant time
windows (minutes to hours) in behaving animals is fundamental to understanding the
function of any one particular circuit within the intact brain. Furthermore, understanding
how circuit function changes with repeated manipulation is important for modeling the
circuit-wide disruptions that occur with chronic disease states. Here, we review recent
advances in optogenetic technology that allow for chronic, temporally specific, control
of circuit activity and provide examples of chronic optogenetic paradigms that have
been utilized in the search for the neural circuit basis of behaviors relevant to human
neuropsychiatric disease.
Keywords: optogenetics, opsins, circadian rhythms, addiction, depression, bipolar disorder, obsessive-compulsive
disorder, mouse models
INTRODUCTION
Optogenetics has transformed the field of neuroscience with its
ability to manipulate neural circuit activity with unprecedented
spatial and temporal precision. Indeed, the ability to manipulate
neural activity at physiologically relevant millisecond timescales
has leveraged an advantage of using optogenetics as a tool to
link time-locked changes in neural activity to behavioral and/or
physiological events and has been instrumental in our under-
standing of the neural circuitry driving an array of behavioral
states (Tye and Deisseroth, 2012; Nieh et al., 2013). Little con-
sideration, however, has been given to (1) the importance of
proper timing for delivery of optogenetic stimulation, (i.e., at
physiologically relevant times of day); and (2) to the overall
duration of manipulation (acute vs. chronic). Although treated
separately for the purpose of this review, these two temporal
considerations are ultimately interconnected: in addition to acute
optogenetic stimulation, the expanding use of chronic stimulation
paradigms, in general, will require attention to the circadian
timing of circuit manipulation; the proposed use of optogenet-
ics to alter circuit rhythms will require extended stimulation
parameters.
CONSIDERATION OF DIURNAL-SPECIFIC CONTROL OF
NEURAL ACTIVITY
The circadian clock is a temporal interface that synchronizes
internal physiological and behavioral events to the external
environment. A core group of proteins generate biological
rhythms in an approximate 24 h cycle (Figure 1). The master
clock governing these rhythms resides in the suprachiasmatic
nucleus (SCN) of the anterior hypothalamus (Ralph et al., 1990)
and coordinates the activity of self-sustained peripheral clocks
(Yoo et al., 2004) that are expressed almost ubiquitously through-
out bodily tissue. Components of the molecular clock are also
found in extra-SCN regions in the central nervous system and
notably in brain regions implicated in mood-regulation and
reward, such as the hippocampus, amygdala, prefrontal cortex,
lateral habenula, nucleus accumbens, and ventral tegmental area
(VTA) of both rodents (Abe et al., 2002; McClung et al., 2005;
Guilding and Piggins, 2007; Webb et al., 2009) and humans
(Li et al., 2013). In addition to exhibiting rhythms in circadian
gene expression, these brain regions exhibit rhythms in neu-
ral firing, neural activity, neurotransmitter levels and receptor
expression (Guilding and Piggins, 2007; Sleipness et al., 2007;
Hampp et al., 2008; Webb et al., 2009; Baltazar et al., 2013).
Perceptible temporal peaks and troughs in neural activity are
observed across brain regions with each displaying a unique
temporal profile of activity. It is proposed that coordinated neural
activity across regions is important for the proper daily timing
of behaviors and avoids co-occurrence of conflicting motiva-
tional states (i.e., feeding vs. sleeping, for example). Therefore,
consideration of not only how neural circuit activity impacts
behavior but also how the timing of stimulation influences a
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FIGURE 1 | The circadian clock machinery. Twenty-four hour rhythms are
generated by a cell-autonomous and autoregulatory
transcriptional-translational feedback loop. In its simplest form, the core
circadian protein, CLOCK, forms a complex with brain and muscle ARNT-like
protein 1 (BMAL1). This complex binds to enhancer box (E-box) regulatory
element and activates transcription of the Period (Per) and Cryptochrome
(Cry ) genes. As PERs and CRYs accumulate during the day, they dimerize
and translocate back to the nucleus where they interact with CLOCK and
BMAL1 to repress their own transcription. As these negative elements are
degraded by casein kinases (CK) at night, repression of CLOCK and BMAL1
is removed, and a new cycle of transcription begins the following morning.
The CLOCK-BMAL1 complex also binds to an array of clock-controlled
genes (ccg) that ultimately regulate biological processes such as
sleep-wake cycles, body temperature, hormone secretion, feeding, and
activity (modified from an original by Mohawk et al., 2012; Frank et al.,
2013).
given behavioral state may yield additional, ethologically relevant
information. This is particularly relevant when studying the
reward system as there is known daily variation in reward-
seeking and drug response in both rodents and humans. For
instance, the reinforcing properties of cocaine are greater dur-
ing the light than dark-phase of the light/dark cycle in rodents
(Abarca et al., 2002). Furthermore, nicotine administration and
sensitivity in rodents and humans follows a daily rhythm, with
more intense periods of administration and sensitivity to nicotine
presenting during the light-cycle (Mooney et al., 2006; Mexal
et al., 2012). Importantly, the propensity to administer drugs
of abuse and the sensitivity to natural reward in rodents has
been linked to diurnal changes in dopaminergic activity within
the mesolimbic system (Webb et al., 2009). Therefore, neural
circuit manipulation during peaks and troughs of activity may
yield more pronounced behavioral responses, i.e., inhibition of
a given circuit when activity is usually highest may be preferred
over inhibiting when activity is at a daily low (Figure 2A).
Alternatively, for long-term stimulation paradigms (discussed in
next section), stimulating a circuit at a time of day that is not in
accordance with its natural rhythm may disrupt overall network
synchrony, which may or may not be the intended experimental
effect.
DIURNAL RHYTHM CHANGES WILL NECESSITATE CHRONIC
STIMULATION PARADIGMS
Conversely, one may want to use optogenetic approaches to
purposefully disrupt or alter diurnal rhythms. Studies that have
employed jet lag paradigms or other types of phase resetting
protocols have demonstrated that days to weeks are required
for an animal to fully adjust/entrain to a new light/dark cycle
(Albrecht, 2012). It stands to reason, therefore, that studies aimed
at altering the amplitude, phase and/or period of neural activity
rhythms will require long stretches of time. This will necessitate
the development of novel stimulation paradigms that permit
both chronic excitation and inhibition within the same neurons.
The prospect of these studies are exciting as they will directly
determine the relevance of diurnal rhythms in select neuronal
populations to disease states and basic brain function.
To exemplify this point, our lab uses the Clock119 mutant
mouse to study how chronic alteration in the daily activity of spe-
cific neural circuits impacts reward and mood-related behaviors.
These mice display a behavioral profile that is strikingly similar
to human bipolar-mania (Roybal et al., 2007) that occurs within
the overall context of disrupted circadian rhythms, driven by a
point mutation in exon19 of the Clock gene (Vitaterna et al., 1994;
King et al., 1997). Behavioral abnormalities include lower levels
of anxiety-like behaviors, decreased depressive-like behaviors,
hyperactivity, reduced sleep time, and increased propensity for
both natural (i.e., sucrose) and drug rewards (Naylor et al., 2000;
Roybal et al., 2007). Lithium treatment, which is used as a mood-
stabilizing agent to treat human bipolar disorder, is also effec-
tive at reversing many of these behavioral abnormalities (Roybal
et al., 2007). Clock119 mutant mice exhibit gross neural circuit
abnormalities that relate to improper timing of neural events,
including altered phase-coupling within the nucleus accumbens
(Dzirasa et al., 2010) and deficits in synchronization of neu-
ral activity across limbic brain regions (Dzirasa et al., 2011).
Additionally, Clock119 mice exhibit profound alterations in the
diurnal activity of the mesolimbic dopamine system, (McClung
et al., 2005; Spencer et al., 2012) which has been shown to underlie
components of their manic-related behavioral profile (Coque
et al., 2011). Although it is intriguing to speculate that altered
circadian clock machinery is the driving force generating these
neural circuit timing-deficits, the exact mechanism has yet to be
fully elucidated. Regardless, the important point to emphasize is
that manipulating the timing, in addition to the direction, of neu-
ral circuit activity is instrumental to understanding how altered
neural activity contributes to abnormal behaviors. This same
principle can be applied to the study of any behavior that exhibits
natural daily rhythms and to the host of chronic disorders that
have been linked to disruptions in biological rhythms (Bass and
Takahashi, 2010; Yu and Weaver, 2011; Albrecht, 2012; McCarthy
and Welsh, 2012; Coogan et al., 2013; Frank et al., 2013).
CHRONIC OPTOGENETIC MODULATION OF NEURAL CIRCUIT
ACTIVITY
In general, understanding how chronic disruption of neural activ-
ity, i.e., that which occurs over the course of many days and
weeks, contributes to the development of abnormal behavior
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FIGURE 2 | Temporal considerations for optogenetic manipulation of
neural activity. (A) Neural activity exhibits natural daily rhythms with
distinct peaks and troughs of activity emerging throughout the 24 h
light/dark cycle. Neural circuit manipulation during these peaks and
troughs may yield more pronounced behavioral effects, i.e., inhibition of a
given circuit when activity is usually highest may be preferred over
inhibiting when activity is at a daily low. This is a generalized concept and
the converse may be equally as valid depending on the type of experiment
performed and the purpose of optogenetic manipulation. (B, left) 1FosB
induction, a marker of chronic neural activity, was measured in striatal
dopamine rececptor-1 (D1) and dopamine receptor 2 (D2) medium spiny
neurons (MSNs) following five consecutive days of optogenetic
stimulation of ChR2-expressing neurons in the following striatal afferents:
medial prefrontal cortex (mPFC), amygdala, ventral hippocampus and the
VTA. Daily optic stimulations involved 10 min bouts of blue light delivered
at 20 Hz, 40 ms for phasic VTA stimulation and at 20 Hz for 30 s for
prefrontal cortex, amygdala, and hippocampal stimulation. (B, right)
Following 7 days of habituation to the tethering protocol, six consecutive
days (T 7–T 12) of optogenetic stimulation were carried in awake
freely-moving mice that involved daily 5 min bouts of stimulation with blue
light, pulsed at 10 Hz (10 ms pulse width). Light was delivered to ChR2
expressing neurons in the orbitofrontal cortex (OFC) to ventromedial
striatal (VMS) projection. Grooming behavior (as a measure of
obsessive-compulsive-like behavior) was measured before (pre-stim),
during (Groomstim), and after (post-stim) optic stimulation. Acute
behavioral responses were assessed immediately following stimulation
and 1 h post-stimulation. Chronic behavioral responses were assessed
during the pre-stim period the following day, as a “24 h time-stamp” of
previous daily stimulations. The persistence of the chronic stimulation
protocol was assessed 2 weeks (T 28) following the last day of stimulation.
may better model the chronic circuit-wide disruptions underlying
neurological disorders, psychiatric disorders, and drug addiction.
One can speculate that perturbing neural circuit activity chroni-
cally may induce neural plastic changes, such as altered synaptic
structuring, altered neural firing properties, and overall network
re-wiring, not induced by acute modulation. Chronic neural cir-
cuit modulation, therefore, has the potential to provide additional
information not revealed by studying acute time-locked neural
responses. Chronic optogenetic stimulation paradigms—defined
as manipulation that occurs across multiple, consecutive days—
have been used by relatively few studies. Their use, as demon-
strated below, can often yield distinct results from those obtained
using acute stimulation protocols. It should be noted that
although we focus on the in vivo use of chronic manipulation,
there are a few in vitro studies that have emerged which use
chronic optogenetic stimulation for various applications (Stroh
et al., 2011; Lignani et al., 2013).
In the first study, Lobo et al. (2013) used a chronic optogenetic
stimulation protocol to determine the circuit-level mechanisms
underlying distinct patterns of protein expression induced in
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striatal neurons in response to chronic stimuli (Figure 2B).
Chronic stimuli such as drugs of abuse, stress, and natural reward
lead to a stable up-regulation of the transcription factor, 1FosB,
in the striatum (McClung et al., 2004). This increase is thought to
be important for the long-term adaptive changes associated with
chronic stimulus exposure. Previous evidence has suggested that
specific chronic stimuli differentially induce 1FosB in specific
subsets of striatal GABAergic projection medium spiny neurons
(MSNs) (McClung et al., 2004; Pitchers et al., 2013). However,
the specific circuits mediating the distinct induction of striatal
1FosB in response to different stimuli were unknown. Lobo et al.
(2013) used a chronic optogenetic approach to stimulate specific
striatal afferents and examined the resulting pattern of 1FosB
induction in dopamine receptor 1 (D1) vs. dopamine receptor 2
(D2) enriched MSNs. To accomplish this, the light-sensitive ion
channel, channelrhodopsin (ChR2), was expressed in the VTA
and in glutamatergic neurons of the ventral hippocampus, medial
prefrontal cortex (mPFC), and amygdala, followed by fiber optic
implantation at the respective cell bodies. Mice received phasic
pulses of blue light at 20 Hz for 40 ms to stimulate VTA neurons
and 20 Hz pulses for 30 s for stimulation of mPFC, amygdala, and
hippocampal neurons. Optic stimulation was delivered for 10 min
a day for five consecutive days and 1FosB was measured in D1
and D2 enriched MSNs 24 h following the last day of the 5 day
stimulation protocol. Chronic optic stimulation of the different
striatal inputs lead to a predominate induction of 1FosB in D1-
MSNs, consistent with previous studies showing that optogenetic
stimulation of these afferents promote reward. Additionally this
demonstrated that repeated episodes of 10 min optic stimulation
were sufficient to induce neural plasticity similar to repeated
exposure to drugs of abuse and natural rewards. The ability to
probe cell-defined and projection-specific circuits leverages an
advantage for using chronic optogenetic stimulation to delineate
the circuit mechanisms driving adaptive neural changes.
In another study, Ahmari et al. (2013) addressed the role
of cortico-striatal dysregulation in obsessive-compulsive disorder
(OCD). There is compelling evidence to suggest a role for hyper-
activity of the orbitofrontal cortex (OFC) and ventromedial stria-
tum (VMS) in OCD pathology (Pittenger et al., 2011), however, a
causal role has been difficult to ascertain. Ahmari and colleagues
employed a chronic optogenetic stimulation protocol to directly
assess the role of repeated cortico-striatal stimulation on OCD-
like behaviors in mice (Figure 2B). To accomplish this, a cre-
dependent virus encoding ChR2 was transduced into glutamater-
gic neurons of the OFC followed by a fiber optic implant in the
VMS to chronically stimulate the OFC-VMS projection pathway.
EMX-cre mice (ensures glutamate cell-type specificity for viral
transduction) received 10 Hz, 10 ms pulses of blue light for 5 min
a day, across multiple days. A sustained, stimulation-independent
increase in OCD-like behavior (as indicated by excessive groom-
ing relative to control mice) was observed following 3 days
of stimulation. Repeated stimulation also led to a progressive
increase in light-evoked VMS neural firing that paralleled the
increase in repetitive grooming behavior. This effect persisted for
2 weeks after cessation of a 6 day stimulation protocol, indicating
that chronic stimulation induced long-term plastic changes at
OFC-VMS synapses. Importantly, changes in grooming behavior
were not seen following acute stimulation, defined as grooming
measured both immediately and 24 h following a single 5 min
stimulation session. This indicates that chronic circuit changes
are required for the expression of specific behaviors that extend
beyond immediate changes in neural firing.
It should be emphasized that the opsins, or light-sensitive ion
channels, used to transduce optic signals to neurons can vastly
affect the permitted time scales used for stimulation. For instance,
the work described above relied on ChR2 for control of neural
activity, which is an opsin with fast channel photokinetics (Nagel
et al., 2003; Boyden et al., 2005). This means that the ion channel
opens and closes on a millisecond timescale in response to light
and that repeated pulses of light are required for prolonged and
sustained activation. This can become problematic as ChR2 has
the potential to desensitize with repeated stimulation (Nagel et al.,
2003), vastly limiting its use for protocols that involve prolonged
periods of stimulation (i.e., over tens of minutes). Furthermore,
repeated stimulation with light irradiances (mW/mm2) required
to activate ChR2 may raise concern over the potential for sig-
nificant heat generation, which can have deleterious effects on
brain tissue (Yizhar et al., 2011a). Moving forward, the use of
optogenetics for more prolonged stimulation will require opsins
that do not readily desensitize and that are more sensitive to lower
powers of light (such as the step-function opsins) (Berndt et al.,
2009; Yizhar et al., 2011b).
TECHNOLOGICAL ADVANCES PERMITTING CHRONIC
OPTOGENETIC STIMULATION
There are a growing number of hardware options available that
are compatible with chronic optogenetic stimulation protocols.
For instance, chronic fiber implants have greatly reduced tissue
damage associated with the repeated removal and insertion of
optical fibers to deep brain structures. These optical neural inter-
faces include a fiber optic, which transmits light to deep brain
structures, and a metal or ceramic ferrule that is secured to the
fiber optic (Aravanis et al., 2007). The ferrule protrudes from the
head for coupling and tethering to an external light source. These
fiber cannulas are relatively simple to make in-house (Sparta et al.,
2012) and can be surgically implanted and secured for chronic use
(Ung and Arenkiel, 2012).
When the duration of the chronic stimulation protocol extends
from minutes to hours and across many days, however, there
are other hardware considerations that need to be made. For
instance, animals are usually tethered to a light source during
acute stimulation, however, more complex chronic stimulation
protocols may involve substantially extended durations of time
whereby prolonged tethering in the homecage or experimental
environment is not possible. Furthermore, for multiple stimula-
tions across a 24 h period, the constant removal and re-tethering
of the animal may induce profound handling stress and have a
negative impact on behavior. In these cases, wireless optogenetic
technology may provide a truly remote and non-invasive system
for chronic control of neural activity and will permit more com-
plex chronic stimulation paradigms across a single day or multiple
days and weeks.
Although the field of wireless optogenetic technology is still
in its infancy, a variety of promising platforms have emerged
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that use infrared or radiofrequency (RF) signaling to remotely
control a head-mounted device. This device can detect and relay
wirelessly generated signals to light-emitting diodes (LEDs) that
are secured directly on the head-mounted device (Iwai et al.,
2011; Wentz et al., 2011; Ameli et al., 2013). This circumvents
the need for tethered fiber optic devices that require a physical
fiber cable connection between an animal and an external light
source. Wireless head-mounted LEDs have been used to stimulate
surface brain structures, such as the motor cortex in Thy1-ChR2
transgenic mice (Iwai et al., 2011), and have been coupled to
implanted fiber optic cannulas for optic stimulation of deeper
brain structures (Wentz et al., 2011). With the advent of red-
shifted opsins, such as C1V1 (Yizhar et al., 2011b; Mattis et al.,
2012) and the newer ReaChR (Lin et al., 2013) designed by Roger
Tsien’s group, deep brain structures can be targeted wirelessly
without the need for a fiber optic insert into the brain. In this case,
a head-mounted red LED would be sufficient to activate opsins
expressed in deep brain structures, as red light scatters less than
blue light and can penetrate into deep tissue more readily.
Micro-LEDs offer a slightly different approach to wireless
control of neural activity whereby a µ-LED is implanted directly
into the brain rather than being mounted on a head-stage (Kim
et al., 2013; McAlinden et al., 2013; McCall et al., 2013). At least
one group has combined these cellular-scale injectable µ-LEDs
with a head-mounted antenna for remote and wireless control
of the chronically implanted µ-LEDs (Kim et al., 2013; McCall
et al., 2013). The implanted LEDs were well tolerated by freely
moving animals and maintained operational functionality up to
the tested maximum of 6 months (Kim et al., 2013). As a proof
of principle for wireless control of neural activity, the authors
connected the implanted µ-LED probe to a head-stage antenna
to detect wirelessly generated RF signals. VTA dopamine neurons
transduced with a cre-dependent ChR2 were tonically stimulated
using this wireless system. Here, tyrosine hydroxylase (TH): Cre
mice received 5 Hz, 5 ms pulses of blue light for 3 min while
behaving in the elevated zero maze—a validated behavioral test
used to assess anxiety-like behaviors. Acute tonic stimulation of
dopamine neurons produced an anxiolytic behavioral response,
independent of locomotor changes, as measured while animals
were being actively stimulated.
Many of these head-mounted devices, however, are bulky and
would benefit from scaling-down to sizes compatible with long-
term use in rodents in order to avoid damage to the hardware
components. Furthermore, it is essential that steps be taken
to ensure adequate detection of wirelessly generated signals as
limited detection ranges/distances may present a current limiting
factor. We look forward to continued advances in the fields of elec-
trical, mechanical, optical, and biological engineering as this will
lead to a vast expansion of technological options permitting novel
and more refined ways to probe the nervous system (Deisseroth
and Schnitzer, 2013).
SUMMARY
Here we propose that the time of day and duration (acute
vs. chronic) of circuit modulation are important experimental
considerations for certain optogenetic applications. Manipula-
tion of neural activity at physiologically-relevant times of day
is an important methodological consideration for both acute
and chronic stimulation of circuits that display natural daily
rhythms. Experiments aimed at altering diurnal rhythms using
optogenetics will necessitate the use of chronic stimulation
paradigms due to the extended timescale required for the entrain-
ment of rhythms. Chronic stimulation paradigms have begun to
emerge with the potential to uncover the neuroplastic events and
circuit-wide disruptions associated with chronic disease states.
Although these temporal considerations may not apply in all
cases, an awareness of their rationale, experimental advantage,
and appropriateness to specific experimental methodologies will
permit more physiologically relevant paradigms for probing neu-
ral circuit function in health and disease.
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